Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2025-04-28 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
Letter to those shareholders who have elected to receive the printed form of corporate communications
Report Publication Announcement Classification · 87% confidence The document is a cover letter to shareholders notifying them that the Annual Report 2024, a Circular dated 28 April 2025, and a proxy form are enclosed and providing instructions on how to elect printed or electronic corporate communications. It is not the Annual Report itself but an announcement of its publication and distribution, fitting the “Report Publication Announcement” category.
2025-04-28 English
Proxy Form
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for shareholders to appoint a proxy and cast votes on resolutions at the upcoming Annual General Meeting. This falls under materials sent to shareholders to solicit votes (proxy solicitation). Therefore, it matches the Proxy Solicitation & Information Statement category (PSI).
2025-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 87% confidence The document is titled “NOTICE OF ANNUAL GENERAL MEETING” and contains the formal notice to shareholders, details of resolutions to be voted on at the upcoming AGM, proxy appointment instructions and mailing details. It is a solicitation of votes and provision of meeting information, rather than the actual minutes, presentation materials, or post-meeting voting results. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2025-04-28 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE THREE MONTHS ENDED 31 MARCH 2025
Report Publication Announcement Classification · 88% confidence The document is an announcement by the parent company that its subsidiary, Dong-E-E-Jiao, has released its quarterly report for the three months ended 31 March 2025. It provides a brief summary and directs readers to the full report on the Shenzhen Stock Exchange website. It does not itself contain the comprehensive quarterly report, but merely notifies stakeholders of its publication and provides key highlights. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA), not the report itself.
2025-04-28 English
PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, RE-ELECTION OF RETIRING DIRECTORS, ELECTION OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a shareholder circular and notice of the Annual General Meeting, containing proposals for general mandates to buy back and issue shares, re-election and election of directors, and instructions for completing proxy forms. It is soliciting votes and providing information for shareholder decision-making at the AGM. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2025-04-28 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF JIANGZHONG PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2025
Earnings Release Classification · 85% confidence The document is a short announcement issued by China Resources Pharmaceutical Group Limited on the Stock Exchange of Hong Kong summarizing key unaudited Q1 financial metrics of its subsidiary, Jiangzhong Pharmaceutical, and directing readers to the full quarterly report on the Shanghai Stock Exchange. It provides headline figures (revenue, net profit, cash balances, assets/liabilities) rather than presenting a full interim financial report. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results with key highlights only). Q1 2025
2025-04-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.